TrialBMC cancer2021

Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial.

F J Hinsenveld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.